The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 23, 2021

Filed:

Feb. 18, 2020
Applicant:

Kempharm, Inc., Celebration, FL (US);

Inventors:

Travis Mickle, Kissimmee, FL (US);

Sven Guenther, Coralville, IA (US);

Guochen Chi, Coralville, IA (US);

Assignee:

KemPharm, Inc., Celebration, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/4545 (2006.01); A61K 47/54 (2017.01); A61K 31/4458 (2006.01); C07D 401/12 (2006.01); C07D 211/34 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 9/0053 (2013.01); A61K 31/4458 (2013.01); A61K 31/4545 (2013.01); A61K 47/545 (2017.08); C07D 211/34 (2013.01);
Abstract

The present technology is directed to compositions comprising d-threo-methylphenidate conjugates and unconjugated methylphenidate. The present technology also relates to compositions and oral formulations comprising d-threo-methylphenidate conjugated to nicotinoyl-L-serine, and/or a pharmaceutically acceptable salt thereof, and unconjugated methylphenidate and/or a pharmaceutically acceptable salt thereof. The present technology additionally relates to a pharmaceutical kit containing the composition comprising d-threo-methylphenidate conjugated to nicotinoyl-L-serine, and/or a pharmaceutically acceptable salt thereof, and unconjugated methylphenidate and/or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…